| Product NDC: | 23359-018 |
| Proprietary Name: | CENTUSSIN DHC |
| Non Proprietary Name: | Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride |
| Active Ingredient(s): | 4; 3; 7.5 mg/5mL; mg/5mL; mg/5mL & nbsp; Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 23359-018 |
| Labeler Name: | Centurion Labs, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20091124 |
| Package NDC: | 23359-018-16 |
| Package Description: | 473 mL in 1 BOTTLE (23359-018-16) |
| NDC Code | 23359-018-16 |
| Proprietary Name | CENTUSSIN DHC |
| Package Description | 473 mL in 1 BOTTLE (23359-018-16) |
| Product NDC | 23359-018 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20091124 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Centurion Labs, LLC |
| Substance Name | BROMPHENIRAMINE MALEATE; DIHYDROCODEINE BITARTRATE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 4; 3; 7.5 |
| Strength Unit | mg/5mL; mg/5mL; mg/5mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |